Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) dedicated to merging with innovative firms in the life sciences sector. Led by a highly seasoned management team with deep expertise in healthcare investments, OACC seeks to capitalize on growth opportunities across diverse areas such as healthcare technology, therapeutics, and medical devices. The company prioritizes strategic partnerships and meticulous due diligence to maximize shareholder value, positioning itself for success in the dynamic and evolving landscape of life sciences.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.28 |
| Price-to-Book | 1.35 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $19.78M |
| Float | $18.37M |
| % Insiders | 0.00% |
| % Institutions | 90.40% |
Volatility is currently contracting